Processes for quality improvements in radiation oncology clinical trials
- PMID: 18406943
- PMCID: PMC2391004
- DOI: 10.1016/j.ijrobp.2007.07.2387
Processes for quality improvements in radiation oncology clinical trials
Abstract
Quality assurance in radiotherapy (RT) has been an integral aspect of cooperative group clinical trials since 1970. In early clinical trials, data acquisition was nonuniform and inconsistent and computational models for radiation dose calculation varied significantly. Process improvements developed for data acquisition, credentialing, and data management have provided the necessary infrastructure for uniform data. With continued improvement in the technology and delivery of RT, evaluation processes for target definition, RT planning, and execution undergo constant review. As we move to multimodality image-based definitions of target volumes for protocols, future clinical trials will require near real-time image analysis and feedback to field investigators. The ability of quality assurance centers to meet these real-time challenges with robust electronic interaction platforms for imaging acquisition, review, archiving, and quantitative review of volumetric RT plans will be the primary challenge for future successful clinical trials.
Conflict of interest statement
Conflict of Interest Statement: No author has any conflicts of interest.
References
-
- Urie M, FitzGerald TJ, Followill D, et al. Current calibration, treatment, and treatment planning techniques among institutions participating in the Children’s Oncology Group. Int J Radiat Oncol Biol Phys. 2003;55:245–60. - PubMed
-
- Urie M, Ulin K, Followill D, et al. Results and analysis by QARC of the IMRT benchmark required by the NCI for Participation in Clinical Trials. MedPhys. 2004;31(6):1915. Abstract.
-
- Weiner MA, Leventhal B, Brecher ML, et al. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin’s disease in pediatric patients: a Pediatric Oncology Group study. J Clin Oncol. 1997;15:2769–79. - PubMed
-
- Carrie C, Hoffstetter S, Gomez F, et al. Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Pediatric Oncology (SFOP) Int J Radiat Oncol Biol Phys. 1999;45:435–9. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials